- Home
- PBFS vs JUNS Comparison
PBFS vs JUNS Comparison
Compare PBFS & JUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBFS
- JUNS
- Stock Information
- Founded
- PBFS 1889
- JUNS 2015
- Country
- PBFS United States
- JUNS United States
- Employees
- PBFS N/A
- JUNS N/A
- Industry
- PBFS Banks
- JUNS
- Sector
- PBFS Finance
- JUNS
- Exchange
- PBFS Nasdaq
- JUNS NYSE
- Market Cap
- PBFS 309.6M
- JUNS 281.4M
- IPO Year
- PBFS N/A
- JUNS 2024
- Fundamental
- Price
- PBFS $11.56
- JUNS $0.63
- Analyst Decision
- PBFS
- JUNS
- Analyst Count
- PBFS 0
- JUNS 0
- Target Price
- PBFS N/A
- JUNS N/A
- AVG Volume (30 Days)
- PBFS 18.9K
- JUNS 113.8K
- Earning Date
- PBFS 05-12-2025
- JUNS 05-11-2025
- Dividend Yield
- PBFS N/A
- JUNS N/A
- EPS Growth
- PBFS 11.77
- JUNS N/A
- EPS
- PBFS 0.76
- JUNS N/A
- Revenue
- PBFS $88,118,000.00
- JUNS N/A
- Revenue This Year
- PBFS N/A
- JUNS N/A
- Revenue Next Year
- PBFS N/A
- JUNS N/A
- P/E Ratio
- PBFS $15.41
- JUNS N/A
- Revenue Growth
- PBFS 21.67
- JUNS N/A
- 52 Week Low
- PBFS $8.76
- JUNS $0.55
- 52 Week High
- PBFS $12.20
- JUNS $19.51
- Technical
- Relative Strength Index (RSI)
- PBFS 42.83
- JUNS N/A
- Support Level
- PBFS $11.49
- JUNS N/A
- Resistance Level
- PBFS $11.78
- JUNS N/A
- Average True Range (ATR)
- PBFS 0.20
- JUNS 0.00
- MACD
- PBFS -0.05
- JUNS 0.00
- Stochastic Oscillator
- PBFS 12.50
- JUNS 0.00
About PBFS Pioneer Bancorp Inc.
Pioneer Bancorp Inc is involved in providing banking services. These services include Personal services such as Checking, Savings, eBanking Cards, and Business services such as Business Deposit and operating Accounts, Business eBanking, and Business loans. Some of the other services of the company include Government Banking, Wealth Management, Benefits Consulting and Insurance.
About JUNS JUPITER NEUROSCIENCES INC
Jupiter Neurosciences Inc is a clinical stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a unique resveratrol platform product primarily targeting treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to most central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.